$0.11
+0.00 (+2.70%)
Open$0.11
Previous Close$0.11
Day High$0.12
Day Low$0.10
52W High$33.66
52W Low—
Volume—
Avg Volume1.43M
Market Cap4.74M
P/E Ratio—
EPS$-0.58
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 7.61M | 6.76M | 8.11M |
| Net Income | 881.2K | 841.9K | 1.08M |
| Profit Margin | 11.6% | 12.5% | 13.3% |
| EBITDA | 1.17M | 1.13M | 1.25M |
| Free Cash Flow | 539.3K | 438.1K | 671.3K |
| Rev Growth | -2.4% | +10.1% | +12.1% |
| Debt/Equity | 0.23 | 0.23 | 0.19 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.64 | -1.05% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $362.12 | +0.44% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.34 | +0.01% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $496.73 | -0.58% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $623.54 | -1.31% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $301.03 | +2.56% | 69.3 | 39.97B |